ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Liposomal Bupivacaine

Also written as “EXPAREL”, “bupivacaine liposome injectable suspension” and “Exparel”.

Its studies are mostly in Pain, Postoperative · Pain · Bunion · Intestinal Obstruction · Hallux Valgus, led by 4 companies.

Drug pageLiposomal Bupivacaine: every studyAll 299 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Oct 23, 201139 company-led studies, 1 open or runningNext primary completion: Jan 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pacira BioSciences361 open or runningphase 4since Oct 23, 2011Oct 23, 2011Jan 2027phase 1 · NCT06271265
Heron Therapeuticsits history only10 open or runningphase 4since Sep 23, 2019Sep 23, 2019none ahead
Jiangsu HengRui Medicineits history only10 open or runningphase 1since Dec 1, 2025Dec 1, 2025none ahead
Nuance Pharma (shanghai)its history only10 open or runningphase 1since Nov 5, 2019Nov 5, 2019none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Pacira BioSciences only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 21 studies since Oct 23, 2011.

  1. May 31, 2017Phase 4 study in AgnosiaNCT03176459 · 186 enrolled · United States
  2. Feb 5, 2018Phase 1 study in Postoperative Pain ManagementNCT03428984 · 5 enrolled · United States
  3. Mar 26, 2018Phase 1 study in Postoperative Pain ManagementNCT03485014 · 15 enrolled · United States
  4. Sep 19, 2018Phase 4 study in AgnosiaNCT03853694 · 167 enrolled · United States
  5. Sep 20, 2018Phase 3 study in Postoperative Pain ManagementNCT03682302 · 98 enrolled · United States
  6. Apr 19, 2019Phase 4 study in Postoperative Pain ManagementNCT03927911 · 65 enrolled · United States
  7. May 14, 2019Phase 4 study in Hip FracturesNCT03955458 · United States
  8. May 15, 2019Phase 3 study in BunionNCT03954639
  9. Jun 25, 2019Phase 1 study in BunionNCT04002089 · 45 enrolled · United States
  10. Nov 18, 2019Phase 1 study in HealthyNCT04173611 · 20 enrolled · United States
  11. Feb 29, 2020Phase 1 study in Breast AugmentationNCT04293809 · 30 enrolled · United States
  12. Aug 4, 2020Phase 3 study in BunionNCT04518462 · 121 enrolled · United States
  13. Nov 15, 20212 phase 3 studiesNCT05157841, NCT05139030
  14. Jan 18, 2024Phase 1 study in Pain, PostoperativeNCT06271265 · 48 planned · United States

Ahead

  1. Jan 2027Primary completion: phase 1 study in Pain, PostoperativeNCT06271265

TargetBeta

SCN4A →read by rule
“Sodium channel protein type IV alpha subunit blocker; Sodium channel protein type IV alpha subunit blocker”ChEMBL 37, by rule

Other programs on SCN4A

ProgramCompanyFurthest phaseStudies
LidocaineruleKeenova Therapeuticsphase 463
LamotrigineruleGlaxoSmithKlinephase 461
RanolazineruleGilead Sciencesphase 426
Carbamazepinerulegrin-therapeutics-incphase 421
DronedaroneruleSanofiphase 418
chloroprocainerulesintetica-saphase 48
RiluzoleruleSanofiphase 46
PrilocaineruleHaisco Pharmaceutical Groupphase 42
CarticaineruleLaboratoires Theaphase 41
Ropivacainerulepainreform-ltdphase 317
QuinidineruleOtsukaphase 317
PhenytoinruleViatrisphase 310

Studies

All 36 Pacira BioSciences leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06271265Pain, Postoperative · United States1RecruitingJan 202748
NCT05157841Hallux Valgus · United States3CompletedAug 17, 2022185
NCT05139030Osteoarthritis, Knee · United States3CompletedJul 11, 2022167
NCT04518462Bunion · United States3CompletedApr 5, 2021121
NCT04293809Breast Augmentation · United States1CompletedJan 15, 202030
NCT04173611Healthy · United States1TerminatedDec 7, 202020
NCT04002089Bunion · United States1CompletedDec 2, 201945
NCT03954639Bunion3WithdrawnSep 20200
NCT03955458Hip Fractures · United States4WithdrawnMay 20200
NCT03927911Postoperative Pain Management · United States4TerminatedAug 4, 202065
NCT03682302Postoperative Pain Management · United States3CompletedAug 30, 201998
NCT03853694Agnosia · United States4CompletedJan 9, 2020167
NCT03485014Postoperative Pain Management · United States1CompletedFeb 12, 201915
NCT03428984Postoperative Pain Management · United States1TerminatedSep 28, 20185
NCT03176459Agnosia · United States4CompletedNov 20, 2018186
NCT02985762Agnosia · United States1CompletedSep 201715
NCT03015961Postoperative Pain Management · United States4TerminatedOct 30, 201738
NCT02713490Pain · United States4CompletedFeb 8, 2017140
NCT02713230Pain · United States, Belgium, Denmark3CompletedJul 7, 2017156
NCT02713178Pain · United States, Belgium, Denmark3CompletedJun 30, 2017232
NCT02353754Pain · United States4TerminatedJun 201512
NCT02255500Pain · United States4CompletedMar 201523
NCT02210247Healthy Volunteers · United States1CompletedSep 201460
NCT02199574Pain · United States4CompletedApr 201512
NCT02142829Obesity · United States4CompletedMar 2013101
NCT02058290Intestinal Obstruction · United States4TerminatedSep 2012122
NCT01919190Pain · United States4TerminatedDec 201367
NCT01919606Pain, Postoperative4TerminatedOct 20121
NCT01802411Pain, Postoperative · United States, Bulgaria, Czechia and more3CompletedJun 2013191
NCT01801124Hernia · United States4CompletedDec 201213
NCT01683071Pain, Postoperative · United States3CompletedDec 2013297
NCT01582477Pain, Postoperative · United States4CompletedMay 201224
NCT01509807Retraction of Colostomy · United States4CompletedOct 201233
NCT01509638Retraction of Colostomy · United States4CompletedOct 201247
NCT01507233Intestinal Obstruction · United States4TerminatedJul 20125
NCT01507246Intestinal Obstruction · United States4CompletedJul 201242

How it is read

Names in the registry

  • “EXPAREL”, 15 entries
  • “bupivacaine liposome injectable suspension”, 4 entries
  • “Exparel”, 3 entries
  • “Exparel Injectable Product”, 2 entries
  • “EXPAREL 266 mg”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.